M7‐FLIPI is not prognostic in follicular lymphoma patients with first‐line rituximab chemo‐free therapy

Summary The clinical course of follicular lymphoma (FL) is highly variable. Recently the m7‐FL international prognostic index (FLIPI) integrating performance status, FLIPI score and the mutational status of seven genes, was shown to stratify patients into “low‐risk” and “high‐risk” with respect to 5...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2020-01, Vol.188 (2), p.259-267
Hauptverfasser:	Lockmer, Sandra, Ren, Weicheng, Brodtkorb, Marianne, Østenstad, Bjørn, Wahlin, Björn E., Pan‐Hammarström, Qiang, Kimby, Eva
Format:	Artikel
Sprache:	eng
Schlagworte:	Chemotherapy chemotherapy‐free Clinical trials follicular lymphoma FOXO1 protein gene sequencing Genes Hematology Immunotherapy Interferon Lymphoma m7‐FLIPI Monoclonal antibodies Mutation Patients Risk groups Rituximab Survival Targeted cancer therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!